日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Mucocutaneous Adverse Events in Patients With Cancer Treated with the Highly Selective RET Kinase Inhibitor Selpercatinib (LOXO-292)

使用高选择性RET激酶抑制剂Selpercatinib（LOXO-292）治疗癌症患者的黏膜皮肤不良事件

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2025.100792
Reingold, Rachel E; Parisi, Rose; Harada, Guilherme; Moy, Andrea P; Dranitsaris, George; Francis, Jasmine H; Canestraro, Julia; Lester, Julia A; Kaplanis, Lauren A; Liu, Dazhi; Lacouture, Mario E; Drilon, Alexander
肿瘤
肿瘤免疫
RET
信号转导
LOX
发表日期：2025
文献求助 收藏

Diagnosis and management of systemic mastocytosis in a community hematology setting

社区血液科环境下系统性肥大细胞增多症的诊断和治疗

期刊:Journal of Oncology Pharmacy Practice
影响因子:0.9
doi:10.1177/10781552231221149
Dranitsaris, George; Neuhalfen, Heather; Peevyhouse, Aaron; Powell, Dakota; Miller, Kerri; Green, Teresa; Graff, Tara
细胞生物学
肥大细胞
发表日期：2025
文献求助 收藏

Drug Interactions between Androgen Receptor Axis-Targeted Therapies and Antithrombotic Therapies in Prostate Cancer: Delphi Consensus

前列腺癌中雄激素受体轴靶向治疗与抗血栓治疗的药物相互作用：德尔菲共识

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers16193336
Leblanc, Kori; Edwards, Scott J; Dranitsaris, George; Leong, Darryl P; Carrier, Marc; Malone, Shawn; Rendon, Ricardo A; Bond, Alison M; Sitland, Troy D; Zalewski, Pawel; Wang, Michelle; Emmenegger, Urban
信号转导
免疫/内分泌
前列腺癌
肿瘤
心血管
肿瘤免疫
发表日期：2024
文献求助 收藏

Impact of a Best Practices Program in Patients with Relapsed/Refractory Multiple Myeloma Receiving Selinexor

最佳实践方案对接受塞利尼索治疗的复发/难治性多发性骨髓瘤患者的影响

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol31010034
Gordan, Lucio N; Ray, David; Ijioma, Stephen C; Dranitsaris, George; Warner, Amanda; Heritage, Trevor; Fink, Matthew; Wenk, David; Chadwick, Paul; Khrystolubova, Natasha; Peles, Shachar
多发性骨髓瘤
骨髓瘤
发表日期：2024
文献求助 收藏

Therapeutic preference for Alzheimer's disease treatments: a discrete choice experiment with caregivers and neurologists

阿尔茨海默病治疗方案的治疗偏好：一项针对照护者和神经科医生的离散选择实验

期刊:Alzheimers Research & Therapy
影响因子:7.6
doi:10.1186/s13195-023-01207-8
Dranitsaris, George; Zhang, Quanwu; Mu, Lin; Weyrer, Christopher; Drysdale, Erik; Neumann, Peter; Atri, Alireza; Monfared, Amir Abbas Tahami
阿尔茨海默症
发表日期：2023
文献求助 收藏

Treatment Preference for Alzheimer's Disease: A Multicriteria Decision Analysis with Caregivers, Neurologists, and Payors

阿尔茨海默病治疗偏好：一项涉及照护者、神经科医生和支付方的多标准决策分析

期刊:Neurology and Therapy
影响因子:4.8
doi:10.1007/s40120-022-00423-y
Dranitsaris, George; Zhang, Quanwu; Quill, Alex; Mu, Lin; Weyrer, Christopher; Dysdale, Erik; Neumann, Peter; Tahami Monfared, Amir Abbas
阿尔茨海默症
发表日期：2023
文献求助 收藏

Dermatological Adverse Events in Prostate Cancer Patients Treated with the Androgen Receptor Inhibitor Apalutamide

接受雄激素受体抑制剂阿帕鲁胺治疗的前列腺癌患者的皮肤不良事件

期刊:Journal of Urology
影响因子:6.8
doi:10.1097/JU.0000000000002425
Pan, Alexander; Reingold, Rachel E; Zhao, Jimmy L; Moy, Andrea; Kraehenbuehl, Lukas; Dranitsaris, George; McBride, Sean M; Scher, Howard I; Kollmeier, Marisa A; Xiao, Han; Rathkopf, Dana E; Lacouture, Mario E
肿瘤
肿瘤免疫
信号转导
前列腺癌
免疫/内分泌
发表日期：2022
文献求助 收藏

Impact of Regulatory Approval Status on CADTH Reimbursement of Oncology Drugs and Role of Real-World Evidence on Conditional Approvals from 2019 to 2021

监管审批状态对加拿大药物与健康技术评估机构 (CADTH) 肿瘤药物报销的影响以及真实世界证据在 2019 年至 2021 年有条件批准中的作用

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol29110635
Lau, Catherine; Dranitsaris, George
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Development of a repeated-measures predictive model and clinical risk score for mortality in ventilated COVID-19 patients

针对接受机械通气的 COVID-19 患者，开发重复测量预测模型和临床风险评分以预测死亡率

期刊:Canadian Journal of Anesthesia-Journal Canadien D Anesthesie
影响因子:3.3
doi:10.1007/s12630-021-02163-3
Bartoszko, Justyna; Dranitsaris, George; Wilcox, M Elizabeth; Del Sorbo, Lorenzo; Mehta, Sangeeta; Peer, Miki; Parotto, Matteo; Bogoch, Isaac; Riazi, Sheila
发表日期：2022
文献求助 收藏

A real-world study to evaluate the safety and efficacy of three injectable neurokinin-1 receptor antagonist formulations for the prevention of chemotherapy-induced nausea and vomiting in cancer patients

一项真实世界研究旨在评估三种注射用神经激肽-1受体拮抗剂制剂在预防癌症患者化疗引起的恶心和呕吐方面的安全性和有效性。

期刊:Supportive Care in Cancer
影响因子:3
doi:10.1007/s00520-022-07082-7
Dranitsaris, George; Moezi, Mehdi; Dobson, Kate; Phelan, Robert; Blau, Sibel
信号转导
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏